• 1
    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005; 28: 29012907.
  • 2
    Jarrett RJ. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 1996; 13(3 suppl2): S15S19.
  • 3
    Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 2001; 24: 447453.
  • 4
    Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (Ausdiab). Circulation 2007; 116: 151157.
  • 5
    Gerstein HC. Glucose: a continuous risk factor for cardiovascular disease. Diabet Med 1997; (14 suppl 3): S25S31.
  • 6
    Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360373.
  • 7
    Sasso FC, Carbonara O, Nasti R, et al. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA 2004; 291: 18571863.
  • 8
    Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997; 20: 18221826.
  • 9
    Victor RG. Arterial hypertension. In: GoldmanL, AusielloD, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007; 430450.
  • 10
    Grossman E, Messerli FH. Hypertension and diabetes. Adv Cardiol 2008; 45: 82106.
  • 11
    Akosah KO, McHugh VL, Barnhart SI, et al. Carotid ultrasound for risk clarification in young to middle-aged adults undergoing elective coronary angiography. Am J Hypertens 2006; 19: 12561261.
  • 12
    Brook RD, Bard RL, Patel S, et al. A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 656662.
  • 13
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr; Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 1422.
  • 14
    Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005; 165: 19101916.
  • 15
    Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004; 141: 413420.
  • 16
    Gerstein HC, Anand S, Yi QL, et al. The relationship between disglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 2003; 26: 144149.
  • 17
    Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt PR; OPTIMAAL Study Group. Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 2007; 154: 470476.